
Diego A. Díaz García/X
Mar 25, 2025, 20:07
Diego A. Díaz García: cfDNA fragmentomics is redefining cancer detection
Diego A. Díaz García, Medical Oncologist /CEO/Founder at CánCare – High Specialty in Oncology, shared on X:
“cfDNA fragmentomics is redefining cancer detection. Beyond mutations and methylation, genome-wide fragmentation patterns offer new biomarkers.
- Reflects genomic and epigenomic states
- Enhances early detection via AI-driven analysis”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 27, 2025, 09:29
Mar 27, 2025, 09:27
Mar 27, 2025, 09:15